| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Adhesion-mediated apoptosis resistance in cancer
|
Westhoff, Mike-Andrew
|
|
2009
|
|
4-5 |
p. 127-136
10 p.
|
artikel
|
| 2 |
Anticancer therapeutics: A surge of new developments increasingly target tumor and stroma
|
Broxterman, Henk J.
|
|
2007
|
|
4-5 |
p. 182-193
12 p.
|
artikel
|
| 3 |
Artemisinins: mechanisms of action and potential for resistance
|
Krishna, Sanjeev
|
|
2004
|
|
4-5 |
p. 233-244
12 p.
|
artikel
|
| 4 |
Autophagy signaling in cancer and its potential as novel target to improve anticancer therapy
|
Moretti, Luigi
|
|
2007
|
|
4-5 |
p. 135-143
9 p.
|
artikel
|
| 5 |
Candida biofilm resistance
|
Mukherjee, Pranab K.
|
|
2004
|
|
4-5 |
p. 301-309
9 p.
|
artikel
|
| 6 |
Editorial Board
|
|
|
2009
|
|
4-5 |
p. i-
1 p.
|
artikel
|
| 7 |
Editorial Board
|
|
|
2006
|
|
4-5 |
p. i-
1 p.
|
artikel
|
| 8 |
Editorial Board
|
|
|
2004
|
|
4-5 |
p. i-
1 p.
|
artikel
|
| 9 |
Editorial Board
|
|
|
2007
|
|
4-5 |
p. i-
1 p.
|
artikel
|
| 10 |
Editorial Board
|
|
|
2008
|
|
4-5 |
p. i-
1 p.
|
artikel
|
| 11 |
Editorial Board
|
|
|
2010
|
|
4-5 |
p. i-
1 p.
|
artikel
|
| 12 |
Editorial Board
|
|
|
2011
|
|
4-5 |
p. i-
1 p.
|
artikel
|
| 13 |
Epidemiology and characteristics of antimicrobial resistance in China
|
Xiao, Yong-Hong
|
|
2011
|
|
4-5 |
p. 236-250
15 p.
|
artikel
|
| 14 |
Epigenetic silencing mediated by CpG island methylation: potential as a therapeutic target and as a biomarker
|
Teodoridis, Jens M.
|
|
2004
|
|
4-5 |
p. 267-278
12 p.
|
artikel
|
| 15 |
Leishmaniasis: drugs in the clinic, resistance and new developments
|
Ouellette, Marc
|
|
2004
|
|
4-5 |
p. 257-266
10 p.
|
artikel
|
| 16 |
Literature Highlights: Recent research in infectious disease drug resistance
|
|
|
2006
|
|
4-5 |
p. 247-258
12 p.
|
artikel
|
| 17 |
Literature highlights: Recent research in infectious disease drug resistance
|
|
|
2007
|
|
4-5 |
p. 194-204
11 p.
|
artikel
|
| 18 |
Literature highlights: recent research in infectious disease drup resistance
|
|
|
2004
|
|
4-5 |
p. 311-315
5 p.
|
artikel
|
| 19 |
Mechanisms of proteasome inhibitor action and resistance in cancer
|
McConkey, David J.
|
|
2008
|
|
4-5 |
p. 164-179
16 p.
|
artikel
|
| 20 |
Meetings Calendar
|
|
|
2009
|
|
4-5 |
p. 137-139
3 p.
|
artikel
|
| 21 |
Meetings Calendar
|
|
|
2006
|
|
4-5 |
p. 259-261
3 p.
|
artikel
|
| 22 |
Meetings Calendar
|
|
|
2007
|
|
4-5 |
p. 205-206
2 p.
|
artikel
|
| 23 |
Meetings Calendar
|
|
|
2008
|
|
4-5 |
p. 200-203
4 p.
|
artikel
|
| 24 |
Methods and biomarkers for the diagnosis and prognosis of cancer and other diseases: Towards personalized medicine
|
Anderson, Judy E.
|
|
2006
|
|
4-5 |
p. 198-210
13 p.
|
artikel
|
| 25 |
Mitotic drug targets and the development of novel anti-mitotic anticancer drugs
|
Schmidt, Mathias
|
|
2007
|
|
4-5 |
p. 162-181
20 p.
|
artikel
|
| 26 |
Molecular mechanisms of platinum resistance: still searching for the Achilles’ heel
|
Wernyj, Roman P.
|
|
2004
|
|
4-5 |
p. 227-232
6 p.
|
artikel
|
| 27 |
Molecular signature and therapeutic perspective of the epithelial-to-mesenchymal transitions in epithelial cancers
|
Sabbah, Michèle
|
|
2008
|
|
4-5 |
p. 123-151
29 p.
|
artikel
|
| 28 |
Patterns of tumor oxygenation and their influence on the cellular hypoxic response and hypoxia-directed therapies
|
Magagnin, Michaël G.
|
|
2006
|
|
4-5 |
p. 185-197
13 p.
|
artikel
|
| 29 |
Prediction of drug sensitivity and drug resistance in cancer by transcriptional and proteomic profiling
|
Alaoui-Jamali, Moulay A.
|
|
2004
|
|
4-5 |
p. 245-255
11 p.
|
artikel
|
| 30 |
Quinoline-resistance reversing agents for the malaria parasite Plasmodium falciparum
|
van Schalkwyk, Donelly A.
|
|
2006
|
|
4-5 |
p. 211-226
16 p.
|
artikel
|
| 31 |
Recent research in infectious disease drug resistance
|
|
|
2008
|
|
4-5 |
p. 180-199
20 p.
|
artikel
|
| 32 |
Repositioning chloroquine and metformin to eliminate cancer stem cell traits in pre-malignant lesions
|
Vazquez-Martin, Alejandro
|
|
2011
|
|
4-5 |
p. 212-223
12 p.
|
artikel
|
| 33 |
Resistance to HIV-1 integrase inhibitors: A structural perspective
|
Mouscadet, Jean-François
|
|
2010
|
|
4-5 |
p. 139-150
12 p.
|
artikel
|
| 34 |
Resistance to polymyxins: Mechanisms, frequency and treatment options
|
Falagas, Matthew E.
|
|
2010
|
|
4-5 |
p. 132-138
7 p.
|
artikel
|
| 35 |
Roots of imatinib resistance: A question of self-renewal?
|
Burchert, Andreas
|
|
2007
|
|
4-5 |
p. 152-161
10 p.
|
artikel
|
| 36 |
Supranational surveillance of antimicrobial resistance: The legacy of the last decade and proposals for the future
|
Giske, Christian G.
|
|
2010
|
|
4-5 |
p. 93-98
6 p.
|
artikel
|
| 37 |
Targeting miRNAs involved in cancer stem cell and EMT regulation: An emerging concept in overcoming drug resistance
|
Wang, Zhiwei
|
|
2010
|
|
4-5 |
p. 109-118
10 p.
|
artikel
|
| 38 |
The fibroblast growth factor receptor signaling pathway as a mediator of intrinsic resistance to EGFR-specific tyrosine kinase inhibitors in non-small cell lung cancer
|
Kono, Scott A.
|
|
2009
|
|
4-5 |
p. 95-102
8 p.
|
artikel
|
| 39 |
The oncogenic PIM kinase family regulates drug resistance through multiple mechanisms
|
Isaac, Methvin
|
|
2011
|
|
4-5 |
p. 203-211
9 p.
|
artikel
|
| 40 |
Therapeutic prospects for p73 and p63: Rising from the shadow of p53
|
Vilgelm, Anna
|
|
2008
|
|
4-5 |
p. 152-163
12 p.
|
artikel
|
| 41 |
Therapeutic targeting of microenvironmental interactions in leukemia: Mechanisms and approaches
|
Konopleva, Marina
|
|
2009
|
|
4-5 |
p. 103-113
11 p.
|
artikel
|
| 42 |
The role of multidrug resistance efflux transporters in antifolate resistance and folate homeostasis
|
Assaraf, Yehuda G.
|
|
2006
|
|
4-5 |
p. 227-246
20 p.
|
artikel
|
| 43 |
The role of tumor initiating cells in drug resistance of breast cancer: Implications for future therapeutic approaches
|
Lacerda, Lara
|
|
2010
|
|
4-5 |
p. 99-108
10 p.
|
artikel
|
| 44 |
Tissue transglutaminase-mediated chemoresistance in cancer cells
|
Verma, Amit
|
|
2007
|
|
4-5 |
p. 144-151
8 p.
|
artikel
|
| 45 |
Translating DNA damage into cancer cell death—A roadmap for E2F1 apoptotic signalling and opportunities for new drug combinations to overcome chemoresistance
|
Engelmann, David
|
|
2010
|
|
4-5 |
p. 119-131
13 p.
|
artikel
|
| 46 |
Translational imaging endpoints to predict treatment response to novel targeted anticancer agents
|
Serkova, Natalie J.
|
|
2011
|
|
4-5 |
p. 224-235
12 p.
|
artikel
|
| 47 |
Understanding the causes of multidrug resistance in cancer: a comparison of doxorubicin and sunitinib
|
Broxterman, Henk J.
|
|
2009
|
|
4-5 |
p. 114-126
13 p.
|
artikel
|
| 48 |
Vascular remodeling and clinical resistance to antiangiogenic cancer therapy
|
Glade Bender, Julia
|
|
2004
|
|
4-5 |
p. 289-300
12 p.
|
artikel
|
| 49 |
Withdrawing antimalarial drugs: impact on parasite resistance and implications for malaria treatment policies
|
Laufer, Miriam K.
|
|
2004
|
|
4-5 |
p. 279-288
10 p.
|
artikel
|
Tijdschrift beschrijving